Advocacy and Public Policy
Shaping Public Policy for Nephrology Health Professionals
ASN promotes the highest quality care by serving as the professional organization informing health policy in kidney disease. Click on the magnifying glass to search by keyword or follow links at the left for more information.
Removing Unintended Consequences in Transplant Regulations
Responding to a Medicare proposed rule designed to relieve regulatory burden in healthcare, the ASN Quality Committee addresses the provisions relating to the process governing re-application for approval of transplant centers.
Posted: Tuesday, November 20, 2018 @ 3:26 PM
Read more »
23 Insurers and Providers Raise Concerns Surrounding the Dialysis PATIENTS Demonstration Act
A coalition of 23 organizations representing major insurers and providers of kidney and transplant care have issued a joint response to the reintroduction of the Dialysis PATIENTS Demonstration Act of 2017. The organizations raise concerns about the possibility of unintended consequences and risks associated with foundational aspects of the PATIENTS Act, including a possible reduction of patient choice, and as such, are unable to support the PATIENTS Act at this time.
Posted: Wednesday, October 31, 2018 @ 5:05 PM
Read more »
Community Responds to Reintroduction of Dialysis PATIENTS Demonstration Act
The American Association of Kidney Patients (AAKP), American Association of Transplantation (AST), American Association of Transplant Surgeons (ASTS), and the American Society of Nephrology (ASN) have issued a joint response to the reintroduction of the Dialysis PATIENTS Demonstration Act of 2017. The organizations remain concerned about the possibility of unintended consequences and risks associated with foundational aspects of the PATIENTS Act, and as such, are unable to support the PATIENTS Act at this time.
Posted: Monday, October 22, 2018 @ 11:08 AM
Read more »
ASN and 35 Kidney Care Organizations Write HHS Secretary Azar in Support of KidneyX
The American Society of Nephrology (ASN) and 35 kidney care organizations wrote to U.S. Department of Health and Human Services (HHS) Secretary Alex Azar, JD, to express their strong support and gratitude for the formation of KidneyX, a public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.
Posted: Wednesday, October 17, 2018 @ 1:43 PM
Read more »
ASN Defending E/M Reimbursement in 2018 Physician Fee Schedule
ASN is opposing a new Medicare proposal to provide a single payment for E/M codes 2 - 5 in its comments on the 2018 proposed rule. The society also addresses proposed changes to documentation and the future of MIPS and AAPMs.
Posted: Thursday, September 13, 2018 @ 3:52 PM
Read more »
ASN Comments on Proposed ESRD Bundle and QIP Rule
ASN provided input to Medicare on its proposed changes to the ESRD bundle and the Quality Incentive Program, including addressing how the agency adds innovative new products to the bundle, encouraging parsimony in the QIP, and requesting clarification on questions related to AKI care in outpatient ESRD units.
Posted: Friday, September 07, 2018 @ 9:46 AM
Read more »
AAKP and ASN Respond to the Dialysis PATIENTS Demonstration Act of 2017
The American Association of Kidney Patients (AAKP) and the American Society of Nephrology (ASN) have issued a joint response to the Dialysis PATIENTS Demonstration Act of 2017.
While staunch proponents of of the move towards value-based care and increasing care coordination for patients with kidney diseases, both organizations remain concerned about the possibility of unintended consequences and risks associated with foundational aspects of the PATIENTS Act.
ASN and AAKP believe that the potential beneficial elements for patients receiving dialysis in the PATIENTS Act could be achieved in more effective ways that minimize or eliminate the potential risks and unintended consequences, and as such, are unable to support the PATIENTS Act at this time.
Posted: Wednesday, February 28, 2018 @ 12:25 PM
Read more »
ASN Calls On Congress to Fund the Agency for Healthcare Research and Quality (AHRQ)
The American Society of Nephrology joined 150 organizations to call on Congress to fund the Agency for Healthcare Research and Quality (AHRQ) in the final FY 18 appropriations package. An essential element of the nation's health care ecosystem, AHRQ is the only federal agency whose sole focus is to generate research on how to deliver the highest quality care to all patients. Crucial to individuals with kidney diseases, AHRQ research also focuses on the best way to deliver care to "real-world" patients who often live with multiple diseases and conditions.
Posted: Tuesday, January 16, 2018 @ 3:34 PM
Read more »